ate effects: Insights into Cardiovascular disease risk after Hodgkin's lymphoma Treatment

Recruiting

• Conditions: 10025319; Cardiovascular diseases; heart disease; 10028593

• Registration Number: NL-OMON35871
• Lead Sponsor: ederlands Kanker Instituut

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 12 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 2000

Inclusion Criteria

- 5 year Hodkin's Lymphoma survivors
- treated in the Netherlands between 1965 and 2005

Exclusion Criteria

- None

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary outcomes are:<br /><br>- Myocardial infarction<br /><br>- Angina Pectoris<br /><br>- Valvular disease<br /><br>- Chronic Heart Failure </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Not applicable</p><br>